Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MYD.DE Stock Summary
In the News
MYD.DE Financial details
Company Rating
Neutral
Market Cap
2.15B
Income
-274.4M
Revenue
734.4M
Book val./share
8.36
Cash/share
1.06
Dividend
-
Dividend %
-
Employees
2.7K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-8.71
Forward P/E
-
PEG
-0.1
P/S
3.21
P/B
3.5
P/C
-
P/FCF
-17.05
Quick Ratio
0.96
Current Ratio
1.27
Debt / Equity
0.29
LT Debt / Equity
0.27
-
-
EPS (TTM)
-3.4
EPS next Y
-
EPS next Q
-
EPS this Y
297.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-4.43%
Revenue Q/Q
4.58%
EPS Q/Q
-47.92%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-24%
ROE
-35%
ROC
-0.29%
Gross Margin
69%
Oper. Margin
-37%
Profit Margin
-37%
Payout
-
Shs Outstand
80.63M
Shs Float
74.59M
-
-
-
-
Target Price
-
52W Range
15.51-30.8
52W High
-
52W Low
-
RSI
-
Rel Volume
0.13
Avg Volume
8
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.963
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
MYD.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2019-06-30 | 2020-06-30 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 11.58 | 8.59 | 7.46 | 8.89 | 8.44 | |
Net income per share | 0.06 | -2.69 | -2.99 | -0.35 | -1.39 | |
Operating cash flow per share | 1.14 | 0.82 | -0.36 | 0.23 | -1.32 | |
Free cash flow per share | 1.02 | 0.68 | -0.54 | 0 | -1.89 | |
Cash per share | 1.86 | 2.93 | 2.02 | 4.37 | 1.43 | |
Book value per share | 14.81 | 12.36 | 11.79 | 12.45 | 11.02 | |
Tangible book value per share | -0.18 | -0.2 | -0.36 | 4.18 | 2.73 | |
Share holders equity per share | 14.81 | 12.36 | 11.79 | 12.45 | 11.02 | |
Interest debt per share | 3.93 | 4.11 | 3.01 | 1.27 | 1.84 | |
Market cap | 1.17B | 794.12M | 1.37B | 2.14B | 2.29B | |
Enterprise value | 1.31B | 925.22M | 1.26B | 1.98B | 2.38B | |
P/E ratio | 254.24 | -3.98 | -6.14 | -78.79 | -20.46 | |
Price to sales ratio | 1.37 | 1.24 | 2.47 | 3.1 | 3.38 | |
POCF ratio | 13.97 | 13.08 | -51.06 | 117.75 | -21.55 | |
PFCF ratio | 15.57 | 15.73 | -34.25 | 10.72K | -15.11 | |
P/B Ratio | 1.07 | 0.86 | 1.56 | 2.21 | 2.59 | |
PTB ratio | 1.07 | 0.86 | 1.56 | 2.21 | 2.59 | |
EV to sales | 1.54 | 1.45 | 2.26 | 2.86 | 3.51 | |
Enterprise value over EBITDA | 15.21 | -21.22 | -10.18 | 140.21 | -35.09 | |
EV to operating cash flow | 15.65 | 15.24 | -46.71 | 108.63 | -22.38 | |
EV to free cash flow | 17.44 | 18.32 | -31.34 | 9.88K | -15.69 | |
Earnings yield | 0 | -0.25 | -0.16 | -0.01 | -0.05 | |
Free cash flow yield | 0.06 | 0.06 | -0.03 | 0 | -0.07 | |
Debt to equity | 0.25 | 0.32 | 0.26 | 0.1 | 0.16 | |
Debt to assets | 0.18 | 0.21 | 0.16 | 0.07 | 0.12 | |
Net debt to EBITDA | 1.63 | -3.01 | 0.95 | -11.78 | -1.3 | |
Current ratio | 2.96 | 2.26 | 2.67 | 2.37 | 2 | |
Interest coverage | 0.63 | -21.45 | 0 | -7.38 | -38.66 | |
Income quality | 18.2 | -0.3 | 0.12 | -0.67 | 0.95 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.65 | 0.8 | 0 | 0.87 | 0.76 | |
Research and developement to revenue | 0.1 | 0.12 | 0.15 | 0.12 | 0.13 | |
Intangibles to total assets | 0.71 | 0.66 | 0.64 | 0.49 | 0.56 | |
Capex to operating cash flow | -0.1 | -0.17 | 0.49 | -0.99 | 0.43 | |
Capex to revenue | -0.01 | -0.02 | -0.02 | -0.03 | -0.07 | |
Capex to depreciation | -0.12 | -0.14 | -0.18 | -0.29 | -0.86 | |
Stock based compensation to revenue | 0.04 | 0.04 | 0.04 | 0.05 | 0.06 | |
Graham number | 4.57 | 27.32 | 28.19 | 9.9 | 18.58 | |
ROIC | 0.01 | -0.16 | -0.21 | -0.02 | -0.08 | |
Return on tangible assets | 0.01 | -0.42 | -0.44 | -0.04 | -0.21 | |
Graham Net | -2.96 | -2.7 | -4.1 | 0.81 | -1.39 | |
Working capital | 230.8M | 184.7M | 243.5M | 280.5M | 137.4M | |
Tangible asset value | -13M | -14.7M | -27M | 324.5M | 219.3M | |
Net current asset value | -125.2M | -154.7M | -148.4M | 131.9M | -38.3M | |
Invested capital | 0.25 | 0.32 | 0.26 | 0.1 | 0.16 | |
Average receivables | 120.35M | 104.8M | 80.25M | 90.4M | 96.45M | |
Average payables | 29.65M | 27.5M | 21.1M | 25.05M | 29.2M | |
Average inventory | 32.85M | 30.25M | 28.1M | 21.2M | 17.7M | |
Days sales outstanding | 59.44 | 40.58 | 58.65 | 48.25 | 54.66 | |
Days payables outstanding | 60.47 | 42.56 | 41.99 | 54.68 | 52.04 | |
Days of inventory on hand | 57.02 | 57.07 | 55.51 | 28.26 | 36.32 | |
Receivables turnover | 6.14 | 8.99 | 6.22 | 7.56 | 6.68 | |
Payables turnover | 6.04 | 8.58 | 8.69 | 6.68 | 7.01 | |
Inventory turnover | 6.4 | 6.4 | 6.58 | 12.92 | 10.05 | |
ROE | 0 | -0.22 | -0.25 | -0.03 | -0.13 | |
Capex per share | -0.12 | -0.14 | -0.18 | -0.23 | -0.56 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.95 | 2.21 | 2.25 | 2.28 | 2.35 | |
Net income per share | -0.44 | -0.53 | -0.68 | -1.44 | -0.75 | |
Operating cash flow per share | -0.02 | -0.1 | -0.41 | -0.01 | -0.27 | |
Free cash flow per share | -0.24 | -0.28 | -0.71 | -0.25 | -0.48 | |
Cash per share | 2.4 | 1.43 | 0.98 | 1.51 | 1.06 | |
Book value per share | 11.4 | 11.02 | 10.39 | 9.14 | 8.36 | |
Tangible book value per share | 3.85 | 2.73 | 2.22 | 1.11 | 0.49 | |
Share holders equity per share | 11.4 | 11.02 | 10.39 | 9.14 | 8.36 | |
Interest debt per share | 1.72 | 1.81 | 2.02 | 2.54 | 2.48 | |
Market cap | 2.11B | 2.29B | 2.34B | 2.34B | 2.31B | |
Enterprise value | 2.14B | 2.38B | 2.45B | 2.44B | 2.44B | |
P/E ratio | -15.04 | -13.54 | -10.71 | -5.04 | -9.44 | |
Price to sales ratio | 13.5 | 12.89 | 12.93 | 12.76 | 12.06 | |
POCF ratio | -1.17K | -297.54 | -70.56 | -2.6K | -104.75 | |
PFCF ratio | -108.29 | -102.74 | -41.32 | -118.86 | -58.46 | |
P/B Ratio | 2.3 | 2.59 | 2.8 | 3.19 | 3.39 | |
PTB ratio | 2.3 | 2.59 | 2.8 | 3.19 | 3.39 | |
EV to sales | 13.67 | 13.38 | 13.52 | 13.31 | 12.72 | |
Enterprise value over EBITDA | -70.57 | -76.01 | -74.94 | -23.88 | -52.94 | |
EV to operating cash flow | -1.19K | -308.99 | -73.81 | -2.71K | -110.42 | |
EV to free cash flow | -109.66 | -106.69 | -43.22 | -123.99 | -61.62 | |
Earnings yield | -0.02 | -0.02 | -0.02 | -0.05 | -0.03 | |
Free cash flow yield | -0.01 | -0.01 | -0.02 | -0.01 | -0.02 | |
Debt to equity | 0.15 | 0.16 | 0.19 | 0.28 | 0.29 | |
Debt to assets | 0.11 | 0.12 | 0.14 | 0.17 | 0.18 | |
Net debt to EBITDA | -0.88 | -2.81 | -3.3 | -0.99 | -2.72 | |
Current ratio | 2.73 | 2 | 1.83 | 1.33 | 1.27 | |
Interest coverage | -56.25 | -51.11 | -104.4 | -227.4 | -60.1 | |
Income quality | 0.05 | 0.18 | 0.61 | 0.01 | 0.36 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.82 | 0.84 | 1.19 | 0.89 | |
Research and developement to revenue | 0.13 | 0.13 | 0.12 | 0.12 | 0.13 | |
Intangibles to total assets | 0.5 | 0.56 | 0.56 | 0.54 | 0.56 | |
Capex to operating cash flow | 9.83 | 1.9 | 0.71 | 20.89 | 0.79 | |
Capex to revenue | -0.11 | -0.08 | -0.13 | -0.1 | -0.09 | |
Capex to depreciation | -1.35 | -1.07 | -1.21 | -1.41 | -1.24 | |
Stock based compensation to revenue | 0.06 | 0.05 | 0.04 | 0.06 | 0.06 | |
Graham number | 10.58 | 11.42 | 12.61 | 17.24 | 11.88 | |
ROIC | -0.03 | -0.03 | -0.05 | -0.1 | -0.06 | |
Return on tangible assets | -0.06 | -0.08 | -0.11 | -0.21 | -0.12 | |
Graham Net | -0.2 | -1.39 | -1.93 | -2.93 | -3.43 | |
Working capital | 223.2M | 137.4M | 118.3M | 73.2M | 56.1M | |
Tangible asset value | 309.3M | 219.3M | 178.7M | 89.2M | 40.2M | |
Net current asset value | 56.9M | -38.3M | -72.5M | -157.7M | -200.3M | |
Invested capital | 0.15 | 0.16 | 0.19 | 0.28 | 0.29 | |
Average receivables | 106M | 101.9M | 110.35M | 115.4M | 113.45M | |
Average payables | 25.65M | 29.2M | 32.65M | 38.15M | 36.85M | |
Average inventory | 17.5M | 19.85M | 20.95M | 22.15M | 23.8M | |
Days sales outstanding | 58.81 | 51.43 | 59.16 | 54.78 | 54.03 | |
Days payables outstanding | 52.86 | 48.09 | 55.49 | 61.97 | 52.97 | |
Days of inventory on hand | 35 | 33.56 | 33.14 | 35.03 | 39.22 | |
Receivables turnover | 1.53 | 1.75 | 1.52 | 1.64 | 1.67 | |
Payables turnover | 1.7 | 1.87 | 1.62 | 1.45 | 1.7 | |
Inventory turnover | 2.57 | 2.68 | 2.72 | 2.57 | 2.29 | |
ROE | -0.04 | -0.05 | -0.07 | -0.16 | -0.09 | |
Capex per share | -0.22 | -0.18 | -0.29 | -0.23 | -0.21 |
MYD.DE Frequently Asked Questions
What is Myriad Genetics, Inc. stock symbol ?
Myriad Genetics, Inc. is a US stock , located in Salt lake city of Ut and trading under the symbol MYD.DE
What is Myriad Genetics, Inc. stock quote today ?
Myriad Genetics, Inc. stock price is $- today.
Is Myriad Genetics, Inc. stock public?
Yes, Myriad Genetics, Inc. is a publicly traded company.